Adenocarcinoma, Bronchiolo-Alveolar - 105 Studies Found
Terminated |
: A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer : Lung Cancer, Non-Small Cell : 2003-11-13 : Drug: GW572016 (lapatinib) tyrosine kinase inhibitor |
Active, not recruiting |
: Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer :
|
Completed |
: Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer :
|
Completed |
: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer :
|
Active, not recruiting |
: Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery :
|
Completed |
: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery :
|
Completed |
: Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer :
|
Completed |
: MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy :
: 2011-02-10 : |
Completed |
: Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature :
|
Recruiting |
: Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery :
: |